Hepatopulmonary syndrome

Victor I. MacHicao, Michaelb Fallon

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Hepatopulmonary syndrome (HPS) is characterized by an oxygenation defect induced by pulmonary vascular dilatation in the setting of liver cirrhosis or portal hypertension. It is defined by an alveolar-arterial gradient > 15 mm Hg measured at sea level. This syndrome is seen in 15 to 30% of cirrhotic patients and has been associated with worse survival. Most HPS patients are either asymptomatic or develop the insidious onset of dyspnea. The key event in its pathogenesis is the development of intrapulmonary vascular dilatation (IPVD), which has been linked to increased pulmonary levels of nitric oxide. Pulse oximetry is a useful screening test for HPS, which can guide subsequent use of arterial blood gases. Contrast-enhanced transthoracic echocardiography is the most effective test to demonstrate IPVD. Another method for detecting IPVD is the radionuclide lung perfusion scanning, using technetium-labeled macroaggregated albumin particles. Liver transplantation is the only available treatment for HPS, resulting in complete resolution or significant improvement in gas exchange in over 85% of patients.

Original languageEnglish (US)
Pages (from-to)11-16
Number of pages6
JournalSeminars in Respiratory and Critical Care Medicine
Volume33
Issue number1
DOIs
StatePublished - Mar 23 2012
Externally publishedYes

Fingerprint

Hepatopulmonary Syndrome
Blood Vessels
Dilatation
Lung
Gases
Oximetry
Technetium
Portal Hypertension
Oceans and Seas
Radioisotopes
Liver Cirrhosis
Liver Transplantation
Dyspnea
Echocardiography
Albumins
Nitric Oxide
Perfusion
Survival

Keywords

  • contrast-enhanced transthoracic echocardiography
  • hepatopulmonary syndrome
  • hypoxemia
  • liver transplantation
  • pulse oximetry

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Hepatopulmonary syndrome. / MacHicao, Victor I.; Fallon, Michaelb.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 33, No. 1, 23.03.2012, p. 11-16.

Research output: Contribution to journalArticle

MacHicao, Victor I. ; Fallon, Michaelb. / Hepatopulmonary syndrome. In: Seminars in Respiratory and Critical Care Medicine. 2012 ; Vol. 33, No. 1. pp. 11-16.
@article{3f06958cbb12425db9a7a9a4c51b4d68,
title = "Hepatopulmonary syndrome",
abstract = "Hepatopulmonary syndrome (HPS) is characterized by an oxygenation defect induced by pulmonary vascular dilatation in the setting of liver cirrhosis or portal hypertension. It is defined by an alveolar-arterial gradient > 15 mm Hg measured at sea level. This syndrome is seen in 15 to 30{\%} of cirrhotic patients and has been associated with worse survival. Most HPS patients are either asymptomatic or develop the insidious onset of dyspnea. The key event in its pathogenesis is the development of intrapulmonary vascular dilatation (IPVD), which has been linked to increased pulmonary levels of nitric oxide. Pulse oximetry is a useful screening test for HPS, which can guide subsequent use of arterial blood gases. Contrast-enhanced transthoracic echocardiography is the most effective test to demonstrate IPVD. Another method for detecting IPVD is the radionuclide lung perfusion scanning, using technetium-labeled macroaggregated albumin particles. Liver transplantation is the only available treatment for HPS, resulting in complete resolution or significant improvement in gas exchange in over 85{\%} of patients.",
keywords = "contrast-enhanced transthoracic echocardiography, hepatopulmonary syndrome, hypoxemia, liver transplantation, pulse oximetry",
author = "MacHicao, {Victor I.} and Michaelb Fallon",
year = "2012",
month = "3",
day = "23",
doi = "10.1055/s-0032-1301730",
language = "English (US)",
volume = "33",
pages = "11--16",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Hepatopulmonary syndrome

AU - MacHicao, Victor I.

AU - Fallon, Michaelb

PY - 2012/3/23

Y1 - 2012/3/23

N2 - Hepatopulmonary syndrome (HPS) is characterized by an oxygenation defect induced by pulmonary vascular dilatation in the setting of liver cirrhosis or portal hypertension. It is defined by an alveolar-arterial gradient > 15 mm Hg measured at sea level. This syndrome is seen in 15 to 30% of cirrhotic patients and has been associated with worse survival. Most HPS patients are either asymptomatic or develop the insidious onset of dyspnea. The key event in its pathogenesis is the development of intrapulmonary vascular dilatation (IPVD), which has been linked to increased pulmonary levels of nitric oxide. Pulse oximetry is a useful screening test for HPS, which can guide subsequent use of arterial blood gases. Contrast-enhanced transthoracic echocardiography is the most effective test to demonstrate IPVD. Another method for detecting IPVD is the radionuclide lung perfusion scanning, using technetium-labeled macroaggregated albumin particles. Liver transplantation is the only available treatment for HPS, resulting in complete resolution or significant improvement in gas exchange in over 85% of patients.

AB - Hepatopulmonary syndrome (HPS) is characterized by an oxygenation defect induced by pulmonary vascular dilatation in the setting of liver cirrhosis or portal hypertension. It is defined by an alveolar-arterial gradient > 15 mm Hg measured at sea level. This syndrome is seen in 15 to 30% of cirrhotic patients and has been associated with worse survival. Most HPS patients are either asymptomatic or develop the insidious onset of dyspnea. The key event in its pathogenesis is the development of intrapulmonary vascular dilatation (IPVD), which has been linked to increased pulmonary levels of nitric oxide. Pulse oximetry is a useful screening test for HPS, which can guide subsequent use of arterial blood gases. Contrast-enhanced transthoracic echocardiography is the most effective test to demonstrate IPVD. Another method for detecting IPVD is the radionuclide lung perfusion scanning, using technetium-labeled macroaggregated albumin particles. Liver transplantation is the only available treatment for HPS, resulting in complete resolution or significant improvement in gas exchange in over 85% of patients.

KW - contrast-enhanced transthoracic echocardiography

KW - hepatopulmonary syndrome

KW - hypoxemia

KW - liver transplantation

KW - pulse oximetry

UR - http://www.scopus.com/inward/record.url?scp=84858727322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858727322&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1301730

DO - 10.1055/s-0032-1301730

M3 - Article

C2 - 22447256

AN - SCOPUS:84858727322

VL - 33

SP - 11

EP - 16

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 1

ER -